Influenza virus neuraminidase activates latent transforming growth factor beta
- PMID: 8970987
- PMCID: PMC190955
- DOI: 10.1128/JVI.70.12.8624-8629.1996
Influenza virus neuraminidase activates latent transforming growth factor beta
Abstract
Transforming growth factor beta (TGF-beta) is a family of proteins secreted by virtually all cells in a biologically inactive form. TGF-beta levels increase during many pathophysiological situations, including viral infection. The mechanism for increased TGF-beta activity during viral infection is not understood. We observed an increase in active TGF-beta levels within 1 day in mice infected with influenza virus. Further studies showed that the neuraminidase glycoprotein of influenza A and B viruses directly activates latent TGF-beta in vitro. There are sufficient levels of TGF-beta activated by virus to induce apoptosis in cells. In addition, influenza virus-induced apoptosis is partially inhibited by TGF-beta-specific antibodies. These novel findings suggest a potential role for activation of TGF-beta during the host response to influenza virus infection, specifically apoptosis. This is the first report showing direct activation of latent TGF-beta by a viral protein.
Similar articles
-
Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis.PLoS Pathog. 2010 Oct 7;6(10):e1001136. doi: 10.1371/journal.ppat.1001136. PLoS Pathog. 2010. PMID: 20949074 Free PMC article.
-
Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors.Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):238-43. doi: 10.1073/pnas.1414422112. Epub 2014 Dec 22. Proc Natl Acad Sci U S A. 2015. PMID: 25535343 Free PMC article.
-
Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus.J Virol. 2000 Jun;74(12):5460-9. doi: 10.1128/jvi.74.12.5460-5469.2000. J Virol. 2000. PMID: 10823850 Free PMC article.
-
Inhibition of sialidase activity as a therapeutic approach.Drug Des Devel Ther. 2018 Oct 10;12:3431-3437. doi: 10.2147/DDDT.S176220. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30349196 Free PMC article. Review.
-
[The rapid detection kit based on neuraminidase activity of influenza virus].Nihon Rinsho. 2000 Nov;58(11):2234-7. Nihon Rinsho. 2000. PMID: 11225310 Review. Japanese.
Cited by
-
Why is coinfection with influenza virus and bacteria so difficult to control?Discov Med. 2015 Jan;19(102):33-40. Discov Med. 2015. PMID: 25636959 Free PMC article.
-
Integrated Analysis of microRNA-mRNA Expression in Mouse Lungs Infected With H7N9 Influenza Virus: A Direct Comparison of Host-Adapting PB2 Mutants.Front Microbiol. 2020 Jul 28;11:1762. doi: 10.3389/fmicb.2020.01762. eCollection 2020. Front Microbiol. 2020. PMID: 32849388 Free PMC article.
-
Influenza A and B Virus-Triggered Epithelial-Mesenchymal Transition Is Relevant to the Binding Ability of NA to Latent TGF-β.Front Microbiol. 2022 Feb 25;13:841462. doi: 10.3389/fmicb.2022.841462. eCollection 2022. Front Microbiol. 2022. PMID: 35283846 Free PMC article.
-
Postinfluenza bacterial pneumonia: host defenses gone awry.J Interferon Cytokine Res. 2010 Sep;30(9):643-52. doi: 10.1089/jir.2010.0049. J Interferon Cytokine Res. 2010. PMID: 20726789 Free PMC article. Review.
-
Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.J Virol. 2005 Jul;79(14):8802-11. doi: 10.1128/JVI.79.14.8802-8811.2005. J Virol. 2005. PMID: 15994774 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
